NSC |
Compound |
Enrichment |
Correlation |
NSC 6926 |
Null |
0.035202825328704 |
0.22102281 |
NSC 700862 |
4H-Cyclopenta[c]thiophen-4-one, 1,3-dichloro- 5,6-dihydro-6-hydroxy- |
0.035202825328704 |
0.44786837 |
NSC 701023 |
Aceanthryleno[1,2-b]quinoxaline, 12-nitro- |
0.035202825328704 |
0.26825533 |
NSC 703784 |
L-Lysinamide, N-[4-(1,3-benzothiazol-2-yl)phenyl-2-chlorophenyl]-,dihydrochloride |
0.035202825328704 |
0.12761093 |
NSC 709358 |
1H-Pyrrole-2-carboxamide, N-[3-(dimethylamino)propyl]-1-methyl-4-[[[1-methyl- 4-[[1-oxo-4-[[(2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]butyl]amino]- 1H-pyrrol |
0.035202825328704 |
0.17356053 |
NSC 709974 |
Null |
0.035202825328704 |
0.38594116 |
NSC 718564 |
Null |
0.035202825328704 |
-0.16117717 |
NSC 718781 |
Erlotinib hydrochloride |
0.035202825328704 |
-0.054547667 |
NSC 726217 |
Combretastatin A4-analogue |
0.035202825328704 |
0.27694272 |
NSC 733149 |
Null |
0.035202825328704 |
0.40152008 |